Literature DB >> 17785013

Pharyngeal gonorrhoea - is dual therapy the way forward?

Leena Sathia, Ben Ellis, Stuart Phillip, Alan Winston, Alan Smith.   

Abstract

Mesh：

Substances：

Year:  2007        PMID： 17785013     DOI： 10.1258/095646207781568556

Source DB:  PubMed          Journal:  Int J STD AIDS        ISSN： 0956-4624            Impact factor:   1.359


× No keyword cloud information.
  12 in total

Review 1.  Preparing for an era of untreatable gonorrhea.

Authors:  Lindley A Barbee
Journal:  Curr Opin Infect Dis       Date:  2014-06       Impact factor: 4.915

2.  Sexually transmitted diseases treatment guidelines, 2015.

Authors:  Kimberly A Workowski; Gail A Bolan
Journal:  MMWR Recomm Rep       Date:  2015-06-05

Review 3.  Emergence of multidrug-resistant, extensively drug-resistant and untreatable gonorrhea.

Authors:  Magnus Unemo; Robert A Nicholas
Journal:  Future Microbiol       Date:  2012-12       Impact factor: 3.165

4.  Gonococcal resistance: are cephalosporins next?

Authors:  Robert D Kirkcaldy; Ronald C Ballard; Deborah Dowell
Journal:  Curr Infect Dis Rep       Date:  2011-04       Impact factor: 3.725

5.  In vitro synergy testing of novel antimicrobial combination therapies against Neisseria gonorrhoeae.

Authors:  Lindley A Barbee; Olusegun O Soge; King K Holmes; Matthew R Golden
Journal:  J Antimicrob Chemother       Date:  2014-01-26       Impact factor: 5.790

Review 6.  The use of cephalosporins for gonorrhea: the impending problem of resistance.

Authors:  Pennan M Barry; Jeffrey D Klausner
Journal:  Expert Opin Pharmacother       Date:  2009-03       Impact factor: 3.889

7.  A retrospective comparative study of 2-drug oral and intramuscular cephalosporin treatment regimens for pharyngeal gonorrhea.

Authors:  Lindley A Barbee; Roxanne P Kerani; Julia C Dombrowski; Olusegun O Soge; Matthew R Golden
Journal:  Clin Infect Dis       Date:  2013-02-13       Impact factor: 9.079

8.  Azithromycin resistance is coevolving with reduced susceptibility to cephalosporins in Neisseria gonorrhoeae in Ontario, Canada.

Authors:  Vanessa G Allen; Christine Seah; Irene Martin; Roberto G Melano
Journal:  Antimicrob Agents Chemother       Date:  2014-02-10       Impact factor: 5.191

9.  Management of Gonorrhea in Adolescents and Adults in the United States.

Authors:  Sarah Kidd; Kimberly A Workowski
Journal:  Clin Infect Dis       Date:  2015-12-15       Impact factor: 9.079

Review 10.  Control of Neisseria gonorrhoeae in the era of evolving antimicrobial resistance.

Authors:  Lindley A Barbee; Julia C Dombrowski
Journal:  Infect Dis Clin North Am       Date:  2013-10-31       Impact factor: 5.982
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.